Poster showing Initial data from the Australian NAIT Registry

Home
About Us
Resources
Our Stories
News
Events
Donate
Contact us

No results See all results

Prophylix Pharma AS (PROFNAIT Project) will take NAITgam into Phase I/II trials in Q3 2015.

November 6, 2014

See Naitbabies news in today’s national newspaper The Independent-Genetics Disorder Campaign 2015

September 18, 2015

Initial summary of data from the Australian NAIT Registry

Prepared by Ri Scarborough, Project Officer.

June 4, 2024

May 2024 – Doctor Thijs W de Vos receives prize for the best dissertation 2023-24 within the field, at the NVB-TRIP Symposium!

May 14, 2024

Care Design New York – Member Spotlight – Meet Chris!!!

April 25, 2024

10 April 2024-FNAIT Collaboration Agreement between Momenta Pharmaceuticals, Inc., a Johnson & Johnson Company, and Rallybio IPA, LLC

If you have been diagnosed with, or suspect that you may have Fetal and neonatal alloimmune thrombocytopenia and would like to join our private parents support forum please email us

Research and treatment protocols are ongoing.

Always consult a qualified medical specialist in this field. Cases of neonatal alloimmune thrombocytopenia should be managed in specialised Fetal Medicine Units.

Follow Our Social Media

Facebook
X
Instagram
Mail

Donate

Home
Privacy Policy
Cookies
Disclaimer

This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.

Initial summary of data from the Australian NAIT Registry

Related posts

May 2024 – Doctor Thijs W de Vos receives prize for the best dissertation 2023-24 within the field, at the NVB-TRIP Symposium!

Care Design New York – Member Spotlight – Meet Chris!!!

10 April 2024-FNAIT Collaboration Agreement between Momenta Pharmaceuticals, Inc., a Johnson & Johnson Company, and Rallybio IPA, LLC